Schedule 13G ownership disclosure

CAMP4 Therapeutics Corp.

Common stock, par value $0.0001 per share · CUSIP: 13463J101

Event date: 2025-09-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LP

    Shares: 4,886,722.00 · Class: 10.0%

  • Coastlands Capital Partners LP

    Shares: 4,886,722.00 · Class: 10.0%

  • Coastlands Capital GP LLC

    Shares: 4,886,722.00 · Class: 10.0%

  • Coastlands Capital LLC

    Shares: 4,886,722.00 · Class: 10.0%

  • Matthew D. Perry

    Shares: 4,886,722.00 · Class: 10.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-004132
Form type
SCHEDULE 13G
Filer
Camp4 Therapeutics Corp
CIK
CIK 1736730
Filed
Sep 16, 2025
Reporting period
Sep 10, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SCHEDULE 13G | SEC Filings Hub